Literature DB >> 3808217

Differentiation in male ferrets of a sexually dimorphic nucleus of the preoptic/anterior hypothalamic area requires prenatal estrogen.

S A Tobet, D J Zahniser, M J Baum.   

Abstract

Experiments were conducted to determine when during perinatal development testicular steroids act in ferrets to promote the organization of a bilateral nucleus in a medial position at the border of the preoptic area (POA) and anterior hypothalamus (AH), henceforth referred to as the male nucleus of the POA/AH (MN-POA/AH). The formation of the MN-POA/AH was promoted in female offspring by treating their mothers with testosterone over the last 11 days of the 42-day gestation period, whereas MN-POA/AH formation was not disrupted in males castrated within 1, 2 or 5 days of birth. Additional experiments were conducted to determine whether the active hormone which induces differentiation of the MN-POA/AH in the male ferret is an androgen or an estrogen. MN-POA/AH formation was inhibited in males deprived prenatally of estrogenic stimulation via maternal ovariectomy and subcutaneous implantation of the aromatase inhibitor 1,4,6-androstatriene-3,17-dione (ATD) on gestational day 30. By contrast, MN-POA/AH formation was not disrupted in males exposed prenatally to the antiandrogen flutamide. These results imply that estrogen, derived from the neural aromatization of circulating testosterone, acts prenatally to promote the organization of the MN-POA/AH in male ferrets. The development of sex-dependent features of forebrain morphology may depend on the neural action of estrogen in males of diverse mammalian species.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3808217     DOI: 10.1159/000124660

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  13 in total

1.  Bilateral damage to the sexually dimorphic medial preoptic area/anterior hypothalamus of male ferrets causes a female-typical preference for and a hypothalamic Fos response to male body odors.

Authors:  Olga V Alekseyenko; Patricia Waters; Huiquan Zhou; Michael J Baum
Journal:  Physiol Behav       Date:  2006-11-21

Review 2.  Estrogenic control of preoptic area development in a carnivore, the ferret.

Authors:  M J Baum; S A Tobet; J A Cherry; R G Paredes
Journal:  Cell Mol Neurobiol       Date:  1996-04       Impact factor: 5.046

3.  Sex- and hormone-dependent antigen immunoreactivity in developing rat hypothalamus.

Authors:  S A Tobet; T O Fox
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  Ventromedial hypothalamic nucleus lesions disrupt olfactory mate recognition and receptivity in female ferrets.

Authors:  Daniel W Robarts; Michael J Baum
Journal:  Horm Behav       Date:  2006-10-02       Impact factor: 3.587

5.  Separate critical periods exist for testosterone-induced differentiation of the brain and genitals in sheep.

Authors:  Charles E Roselli; Charles T Estill; Henry L Stadelman; Mary Meaker; Fred Stormshak
Journal:  Endocrinology       Date:  2011-03-29       Impact factor: 4.736

6.  Sexual Dimorphism in the Brain of the Monogamous California Mouse (Peromyscus californicus).

Authors:  Katharine L Campi; Chelsea E Jameson; Brian C Trainor
Journal:  Brain Behav Evol       Date:  2013-07-19       Impact factor: 1.808

Review 7.  Ontogeny of sex differences in the mammalian hypothalamus and preoptic area.

Authors:  S A Tobet; I K Hanna
Journal:  Cell Mol Neurobiol       Date:  1997-12       Impact factor: 5.046

Review 8.  The neurobiology of sexual partner preferences in rams.

Authors:  Charles E Roselli; Fred Stormshak
Journal:  Horm Behav       Date:  2009-05       Impact factor: 3.587

Review 9.  Sexual differentiation of pheromone processing: links to male-typical mating behavior and partner preference.

Authors:  Michael J Baum
Journal:  Horm Behav       Date:  2009-05       Impact factor: 3.587

10.  Development of vasotocin pathways in the bullfrog brain.

Authors:  S K Boyd
Journal:  Cell Tissue Res       Date:  1994-06       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.